SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-04-080735
Filing Date
2004-05-06
Accepted
2004-05-06 17:15:35
Documents
5
Period of Report
2004-03-31

Document Format Files

Seq Description Document Type Size
1 FOR THE QUARTELY PERIOD ENDED MARCH 31,2004 d10q.htm 10-Q 210754
2 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 7711
3 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 7695
4 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 3781
5 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 3814
  Complete submission text file 0001193125-04-080735.txt   235831
Mailing Address 349 OYSTER POINT BLVD. SUITE 200 SO. SAN FRANCISCO CA 94080
Business Address 349 OYSTER POINT BLVD. SUITE 200 SO. SAN FRANCISCO CA 94080 6506262200
CELLEGY PHARMACEUTICALS INC (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26372 | Film No.: 04786008
SIC: 2834 Pharmaceutical Preparations